Katie Coleman/X
Aug 19, 2024, 10:56
Katie Coleman: Excited to hear about OncoPrimary as an emerging field
Katie Coleman shared a post on X:
“One of the single most difficult corners of my care pre-diagnosis, through active treatment and into post-treatment/surveillance. Excited to hear about OncoPrimary as an emerging field. Excellent session and such an unmet need for so many.”
Source: Katie Coleman/X
Katie Coleman, Product and Engineering Lead at the Rare Cancer Research Foundation and President of the Chromophobe and Oncocytic Tumor Alliance (COA), is a dedicated software engineer with a mission for creating intuitive, user-friendly products.
As a rare kidney cancer survivor, she is deeply committed to medical research and advocacy. Her personal experience helps her to promote collaborations that advance rare cancer research.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 05:59
Dec 22, 2024, 05:31